Baim Institute for Clinical Research, an innovative non-profit academic research organization, leading clinical research, translating results into practice, and measuring change
Many sponsors seeking for approval for innovative, first-in-class medical devices have found that Economic and Quality of Life (EQoL) studies can be a valuable asset in the overall commercialization process
The Dual Antiplatelet Therapy Study (DAPT) was a landmark clinical trial which we designed and managed, with the objective of determining the appropriate duration of dual antiplatelet therapy following placement of a drug-eluting coronary stent.
VIEW ALL STUDIES
Mission
Baim Institute’s mission is to improve health and quality of life by collaborating with academic health systems, industry partners, and patients to conduct high quality clinical research in a professionally nurturing, inclusive, equitable, and world-class academic environment.